Oral Dose Design and Development

April 14, 2020
Catalent

Sponsored Content

Catalent’s Better Treatments by Design™ service offers partners access to solutions and technology to make optimal decisions throughout the development process to achieve successful new treatments that address patient needs.

To be commercially successful in the marketplace, new treatments must offer superior real-world outcomes, and provide market differentiation. Decisions taken during a product’s design and development must be made to deliver the best results for the patients who depend upon their therapies.

 

Catalent is the global leader in drug development and delivery, and offers partners end-to-end solutions in formulation, development, and dose design. Its tools, experience, and expertise ensure the right decisions are made at each stage of development, creating oral dose forms that can improve a drug’s clinical efficacy and commercial success.

 

Catalent’s Better Treatments by Design™ service aims to combine the needs of innovators, prescribers, and patients to create superior products. Using the widest array of drug delivery technologies to overcome each product’s unique challenges and requirements, solutions can be matched to molecules to maximize the potential of a drug, from Phase 2 through to commercial supply.

 

From its global network of facilities, Catalent offers accelerated early drug development, proven bioavailability enhancement solutions, patient-centric drug delivery solutions, and flexible manufacturing of a variety of oral dose forms including softgels, fast-dissolving tablets, modified-release capsules, and stick packs.

 

Related Content:

Sponsored Resources